Xpert HIV-1 qual point-of-care testing for HIV early infant diagnosis in Tanzania: experiences and perceptions of health care workers in a 2016 study.


Journal

AIDS research and therapy
ISSN: 1742-6405
Titre abrégé: AIDS Res Ther
Pays: England
ID NLM: 101237921

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 26 05 2023
accepted: 23 04 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 16 5 2024
Statut: epublish

Résumé

HIV early infant diagnosis (HEID) at the centralized laboratory faces many challenges that impact the cascade of timely HEID. Point of Care (PoC) HEID has shown to reduce test turnaround times, allow for task shifting and has the potential to reduce infant mortality. We aimed at assessing the feasibility of nurse based PoC-HEID in five facilities of Mbeya region. We analysed data from healthcare workers at five obstetric health facilities that participated in the BABY study which enrolled mothers living with HIV and their HIV exposed infants who were followed up until 6 weeks post-delivery. Nurses and laboratory personnel were trained and performed HEID procedures using the Xpert HIV-1 Qual PoC systems. Involved personnel were interviewed on feasibility, knowledge and competency of procedures and overall impression of the use of HIV-1 Qual PoC system in clinical settings. A total of 28 health care workers (HCWs) who participated in the study between 2014 and 2016 were interviewed, 23 being nurses, 1 clinical officer, 1 lab scientist and 3 lab technicians The median age was 39.5 years. Majority of the nurses (22/24) and all lab staff were confident using Gene Xpert PoC test after being trained. None of them rated Gene Xpert handling as too complicated despite minor challenges. Five HCWs (5/24) reported power cut as the most often occurring problem. As an overall impression, all interviewees agreed on PoC HEID to be used in clinical settings however, about half of them (11/24) indicated that the PoC-HEID procedures add a burden onto their routine workload. Overall, health care workers in our study demonstrated very good perceptions and experiences of using PoC HEID. Efforts should be invested on quality training, targeted task distribution at the clinics, continual supportive supervision and power back up mechanisms to make the wide-scale adoption of nurse based PoC HEID testing a possibility.

Sections du résumé

BACKGROUND BACKGROUND
HIV early infant diagnosis (HEID) at the centralized laboratory faces many challenges that impact the cascade of timely HEID. Point of Care (PoC) HEID has shown to reduce test turnaround times, allow for task shifting and has the potential to reduce infant mortality. We aimed at assessing the feasibility of nurse based PoC-HEID in five facilities of Mbeya region.
METHODS METHODS
We analysed data from healthcare workers at five obstetric health facilities that participated in the BABY study which enrolled mothers living with HIV and their HIV exposed infants who were followed up until 6 weeks post-delivery. Nurses and laboratory personnel were trained and performed HEID procedures using the Xpert HIV-1 Qual PoC systems. Involved personnel were interviewed on feasibility, knowledge and competency of procedures and overall impression of the use of HIV-1 Qual PoC system in clinical settings.
RESULTS RESULTS
A total of 28 health care workers (HCWs) who participated in the study between 2014 and 2016 were interviewed, 23 being nurses, 1 clinical officer, 1 lab scientist and 3 lab technicians The median age was 39.5 years. Majority of the nurses (22/24) and all lab staff were confident using Gene Xpert PoC test after being trained. None of them rated Gene Xpert handling as too complicated despite minor challenges. Five HCWs (5/24) reported power cut as the most often occurring problem. As an overall impression, all interviewees agreed on PoC HEID to be used in clinical settings however, about half of them (11/24) indicated that the PoC-HEID procedures add a burden onto their routine workload.
CONCLUSION CONCLUSIONS
Overall, health care workers in our study demonstrated very good perceptions and experiences of using PoC HEID. Efforts should be invested on quality training, targeted task distribution at the clinics, continual supportive supervision and power back up mechanisms to make the wide-scale adoption of nurse based PoC HEID testing a possibility.

Identifiants

pubmed: 38755626
doi: 10.1186/s12981-024-00619-2
pii: 10.1186/s12981-024-00619-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : German Centre for Infectious Diseases (DZIF)
ID : TTU 04.903
Organisme : German Centre for Infectious Diseases (DZIF)
ID : TTU 04.703

Informations de copyright

© 2024. The Author(s).

Références

UNAIDS Global AIDS Monitoring data, 2022. 2022;
National guidelines for the management of HIV and AIDS, The United Republic of Tanzania 2019(255):1–16.
Mofenson LM, Cohn J, Sacks E. Challenges in the early infant HIV diagnosis and. JAIDS J Acquired Immune Defic Syndr. 2020;84:1–4.
doi: 10.1097/QAI.0000000000002366
Boeke CE, et al. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries. J Int AIDS Soc. 2021. https://doi.org/10.1002/JIA2.25677 .
doi: 10.1002/JIA2.25677 pubmed: 33745234 pmcid: 7981587
WHO. Hiv Prevention, Infant Diagnosis, Antiretroviral Initiation and Monitoring Guidelines. 2021.
World Health Organization. Information Note - Novel Point-of-Care Tools for Early Infant Diagnosis of HIV. Geneva: World Health Organization; 2017. p. 1–2.
Ankrah AK, Dako-Gyeke P. Factors influencing the delivery and uptake of early infant diagnosis of HIV services in Greater Accra, Ghana: a qualitative study. PLoS ONE. 2021;16:1–16. https://doi.org/10.1371/journal.pone.0246876 .
doi: 10.1371/journal.pone.0246876
Wexler C, et al. Implementing at-birth, point-of-care HIV testing in Kenya: a qualitative study using the Consolidated Framework for Implementation Research. Implement Sci Commun. 2021;9:1–13.
Sabi I, et al. Accuracy and operational characteristics of Xpert human immunodeficiency virus point-of-care testing at birth and until week 6 in human immunodeficiency virus-exposed neonates in Tanzania. Clin Infect Dis. 2019;68(4):615–22. https://doi.org/10.1093/cid/ciy538 .
doi: 10.1093/cid/ciy538 pubmed: 29961841
D. M. Device. Xpert ® HIV-1 Qual. 2015.
D. M. Device, “Xpert ® HIV-1 Viral Load. 2015.
Mohamed Y, et al. Feasibility and acceptability of implementing early infant diagnosis of HIV in Papua New Guinea at the point of care: a qualitative exploration of health worker and key informant perspectives. BMJ Open. 2020;10(11):1–10. https://doi.org/10.1136/bmjopen-2020-043679 .
doi: 10.1136/bmjopen-2020-043679
Meggi B, et al. Performance of point-of-care birth HIV testing in primary health care clinics: an observational cohort study. PLoS ONE. 2018;13(6):1–11. https://doi.org/10.1371/journal.pone.0198344 .
doi: 10.1371/journal.pone.0198344
Simmonds FM, Cohn JE, Mafaune HW, Nyamundaya TH, Mahomva A, Chadambuka A. Task shifting for point-of-care early infant diagnosis: a comparison of the quality of testing between nurses and laboratory personnel in Zimbabwe. Hum Resour Health. 2020;18(1):1–7. https://doi.org/10.1186/S12960-020-0449-2/TABLES/6 .
doi: 10.1186/S12960-020-0449-2/TABLES/6
Spooner E, et al. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health. 2019;19(1):731. https://doi.org/10.1186/s12889-019-6990-z .
doi: 10.1186/s12889-019-6990-z pubmed: 31185962 pmcid: 6560857
Tembo T, et al. ‘Testing can be done anywhere’: a qualitative assessment of targeted community-based point-of-care early infant diagnosis of HIV in Lusaka, Zambia. Glob Health Sci Pract. 2022;10(3): e2100723. https://doi.org/10.9745/GHSP-D-21-00723 .
doi: 10.9745/GHSP-D-21-00723 pubmed: 36332072 pmcid: 9242615
World Health Organization. WHO prequalification of in vitro diagnostics PUBLIC REPORT Product : care HPV

Auteurs

Siriel Boniface (S)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Anange Lwilla (A)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania. alwilla@nimr-mmrc.org.

Hellen Mahiga (H)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Doreen Pamba (D)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.
CIHLMU Center for International Health, University Hospital, LMU Munich, Munich, Germany.

Otto Geisenberger (O)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
German Center for Infection Research (DZIF), Munich, Germany.

John France (J)

Department of Obstetrics and Gynaecology, Mbeya Zonal Referral Hospital, Mbeya, Tanzania.

Rebecca Mokeha (R)

Department of Obstetrics and Gynaecology, Mbeya Zonal Referral Hospital, Mbeya, Tanzania.

Lilian Njovu (L)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Abisai Kisinda (A)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Nyanda Elias Ntinginya (NE)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Michael Hoelscher (M)

German Center for Infection Research (DZIF), Munich, Germany.

Arne Kroidl (A)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
German Center for Infection Research (DZIF), Munich, Germany.
CIHLMU Center for International Health, University Hospital, LMU Munich, Munich, Germany.

Issa Sabi (I)

National Institute for Medical Research, Mbeya Medical Research Center, P.O.Box 2410, Mbeya, Tanzania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH